Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
56.70
+1.17 (2.11%)
At close: Apr 30, 2026

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Pharmaceutical Manufacturing
801.14M359.90M91.29M
10.29M27.76M
Pharmaceutical Manufacturing Growth
122.60%294.24%-
-62.95%-32.32%
Total
801.14M359.90M91.29M
10.29M27.76M
Total Growth
122.60%294.24%-
-62.95%-32.32%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
China
801.14M--
--
Total
801.14M--
--
Source: S&P Global Market Intelligence.